Loading…
Disc Medicine, Inc. is projected to rise to $100.38 by 2027, a +31% move from its current price of $76.59. IRON is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $75.11 | $76.63 | $78.19 | +0.06% |
| Jul 14 | $74.53 | $76.68 | $78.88 | +0.11% |
| Jul 15 | $74.10 | $76.72 | $79.43 | +0.17% |
| Jul 16 | $73.74 | $76.76 | $79.91 | +0.23% |
| Jul 17 | $73.43 | $76.81 | $80.33 | +0.28% |
| Jul 18 | $73.16 | $76.85 | $80.72 | +0.34% |
| Jul 19 | $72.91 | $76.89 | $81.09 | +0.39% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $72.91 | $76.89 | $81.09 | +0.39% |
| Week 2 | $71.61 | $77.20 | $83.22 | +0.79% |
| Week 3 | $70.69 | $77.50 | $84.97 | +1.19% |
| Week 4 | $69.96 | $77.81 | $86.53 | +1.59% |
| Week 5 | $69.37 | $78.11 | $87.97 | +1.99% |
| Week 6 | $68.85 | $78.42 | $89.32 | +2.39% |
| Week 7 | $68.41 | $78.73 | $90.61 | +2.80% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Disc Medicine, Inc., together with its subsidiaries, is a clinical-stage biopharmaceutical company that engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. Its portfolio targets fundamental biological pathways involved in the formation and function of red blood cells, with a focus on heme biosynthesis and iron homeostasis. The pipeline includes bitopertin for erythropoietic porphyrias (including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia), DISC-0974 for anemia of myelofibrosis and anemia of chronic kidney disease, and DISC-3405 for polycythemia vera and other hematologic disorders.
Preclinical work includes DISC-0998 for anemia associated with inflammatory diseases. The company was founded in 2017 and is headquartered in Watertown, Massachusetts.
Disc Medicine, Inc. trades under the symbol IRON and is currently priced at $76.26. It has a market capitalization of $2.91B and is ranked 1730 by market capitalization among healthcare names.
A major floor 24.1% below — a decisive break under it would weaken the trend.
The nearest floor, 14.1% below — buyers have tended to step in here.
The nearest ceiling, 4.5% above — a clean break opens room to run.
A major ceiling 15.4% above — clearing it would confirm fresh momentum.
Key IRON support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IRON market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $78.47 | Sell | $77.68 | Sell |
| MA 10 | $76.60 | Sell | $76.42 | Buy |
| MA 20 | $73.24 | Buy | $74.25 | Buy |
| MA 50 | $70.15 | Buy | $71.36 | Buy |
| MA 100 | $67.43 | Buy | $70.51 | Buy |
| MA 200 | $74.14 | Buy | $69.45 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.75 | Neutral |
| Stoch RSI (14) | 30.66 | Neutral |
| CCI (20) | 66.29 | Neutral |
| Williams %R (14) | -35.05 | Info |
| MACD (12,26,9) | 0.53 | Buy |
| ROC (12) | 8.72 | Buy |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 64.95 | Neutral |
| TRIX (15) | 0.41 | Buy |
| Awesome (5,34) | 7.10 | Buy |
| Ultimate (7,14,28) | 65.53 | Neutral |
| Momentum (10) | 6.43 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 79.90 | Sell |
| ADX (14) | 21.43 | Buy |
| ATR (14) | 1.33 | Info |
Technical momentum is bullish with RSI at 70. The stock is trading above both the SMA50 of $69.16 and the SMA200 of $73.71, suggesting constructive near-term dynamics. Support is at $65.80 and resistance at $76.26, framing a near-term base and ceiling.
The 30-day price range spans from $66.59 to $87.34, indicating potential for further movement within that band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $55.95 | $76.59 | $104.65 | 0% | Neutral | |
| $81.88 | $100.38 | $128.91 | +31% | Bullish | |
| $101.38 | $126.79 | $167.49 | +66% | Bullish | |
| $119.22 | $151.57 | $204.73 | +98% | Bullish | |
| $131.99 | $170.24 | $234.32 | +122% | Bullish | |
| $143.14 | $187.04 | $261.74 | +144% | Bullish | |
| $147.98 | $195.71 | $277.99 | +156% | Bullish | |
| $166.53 | $222.75 | $320.71 | +191% | Bullish | |
| $191.26 | $258.56 | $376.95 | +238% | Bullish | |
| $213.46 | $291.53 | $429.99 | +281% | Bullish | |
| $295.02 | $421.65 | $653.28 | +451% | Bullish | |
| $674.76 | $1,040.45 | $1,733.63 | +12.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $55.95 | $76.59 | $90.81 | +0.00% |
| August 2026 | $65.84 | $77.15 | $92.44 | +0.74% |
| September 2026 | $68.45 | $80.63 | $97.41 | +4.50% |
| October 2026 | $70.96 | $83.95 | $102.14 | +4.13% |
| November 2026 | $70.85 | $84.14 | $102.96 | +0.22% |
| December 2026 | $71.38 | $85.06 | $104.65 | +1.10% |
Click any year to see its month-by-month IRON forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect IRON to range from $55.95 to $104.65 through 2026. The $76.59 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The IRON price prediction for 2027 points to an average of $100.38 (low $81.88, high $128.91) — a potential gain of +31% on today's $76.59. Momentum favours further upside here.
In 2028, IRON is projected to trade between $101.38 and $167.49, averaging $126.79 — a potential gain of +66% from today's $76.59. That is up +26% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Disc Medicine, Inc.'s 2029 outlook centres on $151.57, within a $119.22 to $204.73 range. That is up +20% on the projected 2028 average. That marks a +98% change versus current levels. Momentum favours further upside here.
By 2030, IRON could reach as high as $234.32, with a base case around $170.24 and support toward $131.99 — roughly +122% from $76.59. Buyers look set to stay in control over this stretch.
Expect IRON to range from $143.14 to $261.74 through 2031. The $187.04 average target implies a +144% move from current prices. That is up +10% on the projected 2030 average. Momentum favours further upside here.
The IRON price prediction for 2032 points to an average of $195.71 (low $147.98, high $277.99) — a potential gain of +156% on today's $76.59. Buyers look set to stay in control over this stretch.
In 2033, IRON is projected to trade between $166.53 and $320.71, averaging $222.75 — a potential gain of +191% from today's $76.59. That is up +14% on the projected 2032 average. Momentum favours further upside here.
Disc Medicine, Inc.'s 2034 outlook centres on $258.56, within a $191.26 to $376.95 range. That is up +16% on the projected 2033 average. That marks a +238% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, IRON could reach as high as $429.99, with a base case around $291.53 and support toward $213.46 — roughly +281% from $76.59. Momentum favours further upside here.
Expect IRON to range from $295.02 to $653.28 through 2040. The $421.65 average target implies a +451% move from current prices. That is up +45% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The IRON price prediction for 2050 points to an average of $1,040.45 (low $674.76, high $1,733.63) — a potential gain of +12.6x on today's $76.59. Momentum favours further upside here.
Investing $1,000 in IRON today (≈ 13.056535 IRON) could be worth
$13,584.7
+$12,584.7 (+1258%) by 2050 · US Dollar
Based on the average projected IRON price of $1,040.45 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IRONwould be worth at today's price.
$1,000 invested in IRON on Jul 10, 2025 (≈ 17.241379 IRON) would be worth
$1,320.52
+$320.52 (+32.1%) today · 1.32× · US Dollar
Based on a IRON entry price of $58 vs. today's $76.59.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $76.26 | $1,004.33 | +0.4% |
| 1 month ago | $67.25 | $1,138.88 | +13.9% |
| 3 months ago | $66.32 | $1,154.86 | +15.5% |
| 6 months ago | $79.02 | $969.25 | -3.1% |
| 1 year ago | $58 | $1,320.52 | +32.1% |
| All time (5.0y) ago | $161.7 | $473.65 | -52.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IRON forecast.
Our base-case forecast reaches $150.00 around 2029.
Implied market cap at $150.00: $5.73B
The multi-year forecast shows a bullish trajectory after 2026. In 2026, the average price is $76.26 with a min of $55.95 and a max of $106.12 (ROI 0%, sentiment NEUTRAL). From 2027 onward, the outlook remains bullish with rising averages and ROIs: 2027 avg $102.36, ROI 34.2%, 2028 avg $129.45, ROI 69.8%, 2029 avg $157.76, ROI 106.9%, 2030 avg $176.35, ROI 131.3%.
By 2040 the forecast shows an average of $455.04 and ROI of 496.7%, with 2050 an average of $1,148.94 and ROI of 1406.6%. Overall, the trend depicted is bullish across the long horizon, but these are estimates and not guarantees, reflecting potential upside with substantial uncertainty and variability.
Tap a question to reveal the answer.
2030 forecast shows an average price of $176.35, a min of $136.27, a max of $243.80, ROI 131.3%, sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward with rising averages and ROIs (e.g., 2027 avg $102.36, ROI 34.2%; 2028 avg $129.45, ROI 69.8%; 2029 avg $157.76, ROI 106.9%; 2030 avg $176.35, ROI 131.3%). The 2026 view is Neutral. These are estimates, not guarantees.
Yes—the 2030 max forecast is $243.80.
Current price is $76.26; market cap is $2.91B.
2040 forecast shows avg $455.04, min $316.38, max $709.57, ROI 496.7%, sentiment BULLISH.
Disc Medicine, Inc. Community Discussion
0Share your Disc Medicine, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.